Regulatory T-cell response to low-dose interleukin-2 in ischemic heart disease

TX Zhao, RS Sriranjan, ZK Tuong, Y Lu… - NEJM …, 2022 - evidence.nejm.org
Background Atherosclerosis is a chronic inflammatory disease of the artery wall. Regulatory
T cells (Tregs) limit inflammation and promote tissue healing. Low doses of interleukin (IL)-2 …
被引用次数：23 相关文章

Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease

TX Zhao, R Sriranjan, Z Tuong, A Sage, M Nus… - 2021 - repository.cam.ac.uk
BACKGROUND Atherosclerosis is a chronic inflammatory disease of the artery wall.
Regulatory T cells (Tregs) limit inflammation and promote tissue healing. Low doses of …

Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease

TX Zhao, RS Sriranjan, ZK Tuong, Y Lu… - NEJM …, 2022 - pubmed.ncbi.nlm.nih.gov
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease This
phase 1b/2a, randomized, double-blind, placebo-controlled, dose-escalation trial tested low …

Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease.

TX Zhao, RS Sriranjan, ZK Tuong, Y Lu, AP Sage… - NEJM …, 2021 - europepmc.org
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease This
phase 1b/2a, randomized, double-blind, placebo-controlled, dose-escalation trial tested low …